Company Filing History:
3 out of 5,094 
2 out of 23 
1 out of 4 Years Active: 2012-2022
Title: Jean Mazella - Innovator in Neuropharmacology
Introduction
Jean Mazella is a prominent inventor based in Biot, France, known for his significant contributions to the field of neuropharmacology. With a focus on developing innovative treatments for depression, he has been instrumental in advancing our understanding of neuropeptides and their therapeutic potential.
Latest Patents
Mazella holds three patents, with his latest innovations including peptides derived from the propeptide NTSR3, which are disclosed for their use in treating depression. These new peptides target the neurotensin receptor 3 (NTSR3) and offer promising avenues for addressing various diseases, particularly mood disorders. Additionally, he has developed retro-inverso analogs of spadin that exhibit enhanced antidepressant effects. His work includes compositions and methods for treating depression using these analogs, as well as strategies for blocking TREK-1 channel activity.
Career Highlights
Throughout his career, Jean Mazella has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Medincell. His research has not only contributed to the scientific community but has also paved the way for potential clinical applications in mental health.
Collaborations
Mazella has collaborated with notable colleagues, including Catherine Louise Heurteaux and Marc Borsotto, further enriching his research endeavors and expanding the impact of his work in the field.